Skip to main content
Clinical Trials/TCTR20171127002
TCTR20171127002
Recruiting
Phase 3

PROPOFOL VERSUS MIDAZOLAM FOR CONSCIOUS SEDATION ADMINISTERED BY THE NURSE UNDER ENDOSCOPIST’S SUPERVISION IN PATIENTS UNDERGOING ELECTIVE ESOPHAGOGASTRODUODENOSCOPY: THE IMPACT ON ENDOSCOPY UNIT EFFICIENCY

/A0 sites200 target enrollmentNovember 27, 2017

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
/A
Enrollment
200
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 27, 2017
End Date
March 31, 2018
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
/A

Eligibility Criteria

Inclusion Criteria

  • Elective esophagogastroduodenoscopy with ASA class I\-II and no severe comorbidity

Exclusion Criteria

  • Severe comorbidity
  • ASA class III\-IV
  • Pregnancy and Lactating woman

Outcomes

Primary Outcomes

Not specified

Similar Trials